{"transactions":[{"id":729126,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-06-23T21:24:25.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":1266903,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 100% with respect to the performance stock units granted to the Reporting Person on May 13, 2025. As a result, 1,266,903 shares vested on June 22, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 100% with respect to the performance stock units granted to the Reporting Person on May 13, 2025. As a result, 1,266,903 shares vested on June 22, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1266903},"source":{"system":"sec-edgar","filing":"0001443841-26-000007","document":"wk-form4_1782249862.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000144384126000007/wk-form4_1782249862.xml","form_type":"4"}},{"id":729125,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:24:25.000Z","date":"2026-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":612549,"price":38.32,"value":23472877.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld to satisfy tax withholding obligations associated with the vesting of performance stock units on June 22, 2026."}],"balance_after":790330,"source":{"system":"sec-edgar","filing":"0001443841-26-000007","document":"wk-form4_1782249862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000144384126000007/wk-form4_1782249862.xml","form_type":"4"}},{"id":729124,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:24:25.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":1266903,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 100% with respect to the performance stock units granted to the Reporting Person on May 13, 2025. As a result, 1,266,903 shares vested on June 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1402879,"source":{"system":"sec-edgar","filing":"0001443841-26-000007","document":"wk-form4_1782249862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000144384126000007/wk-form4_1782249862.xml","form_type":"4"}},{"id":907548,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:02:57.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":79976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":135976,"source":{"system":"sec-edgar","filing":"0001443841-26-000004","document":"wk-form4_1770930173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000144384126000004/wk-form4_1770930173.xml","form_type":"4"}},{"id":1643040,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-14T21:13:23.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":81422,"price":33.7,"value":2743921.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":444867,"source":{"system":"sec-edgar","filing":"0001062993-24-003166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299324003166/form4.xml","form_type":"4"}},{"id":1643039,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-14T21:13:23.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":47445,"price":33.7,"value":1598896.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":526289,"source":{"system":"sec-edgar","filing":"0001062993-24-003166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299324003166/form4.xml","form_type":"4"}},{"id":1643038,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-14T21:13:23.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":179734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 179,734 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":573734,"source":{"system":"sec-edgar","filing":"0001062993-24-003166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299324003166/form4.xml","form_type":"4"}},{"id":1643037,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-14T21:13:23.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":119000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":394000,"source":{"system":"sec-edgar","filing":"0001062993-24-003166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299324003166/form4.xml","form_type":"4"}},{"id":1700744,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-12-22T21:36:26.000Z","date":"2023-12-21","kind":"exercise","planned":true,"acquired":false,"shares":4357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":16875,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":4357},"source":{"system":"sec-edgar","filing":"0001062993-23-023100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323023100/form4.xml","form_type":"4"}},{"id":1700743,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-22T21:36:26.000Z","date":"2023-12-21","kind":"sale","planned":true,"acquired":false,"shares":4357,"price":30.3825,"value":132376.5525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.13 to $30.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001062993-23-023100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323023100/form4.xml","form_type":"4"}},{"id":1700742,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-22T21:36:26.000Z","date":"2023-12-21","kind":"exercise","planned":true,"acquired":true,"shares":4357,"price":21.34,"value":92978.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."}],"balance_after":279357,"source":{"system":"sec-edgar","filing":"0001062993-23-023100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323023100/form4.xml","form_type":"4"}},{"id":1703282,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-20","kind":"exercise","planned":true,"acquired":false,"shares":26454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":21232,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":26454},"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1703281,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-19","kind":"exercise","planned":true,"acquired":false,"shares":14516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":47686,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":14516},"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1703280,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-18","kind":"exercise","planned":true,"acquired":false,"shares":27798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":62202,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":27798},"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1703279,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-20","kind":"sale","planned":true,"acquired":false,"shares":26454,"price":30.4003,"value":804209.5362,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.64, inclusive."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1703278,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-20","kind":"exercise","planned":true,"acquired":true,"shares":26454,"price":21.34,"value":564528.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."}],"balance_after":301454,"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1703277,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-19","kind":"sale","planned":true,"acquired":false,"shares":14516,"price":30.0318,"value":435941.6088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.185, inclusive."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1703276,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-19","kind":"exercise","planned":true,"acquired":true,"shares":14516,"price":21.34,"value":309771.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."}],"balance_after":289516,"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1703275,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-18","kind":"sale","planned":true,"acquired":false,"shares":27798,"price":30.0358,"value":834935.1684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1703274,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-20T22:51:55.000Z","date":"2023-12-18","kind":"exercise","planned":true,"acquired":true,"shares":27798,"price":21.34,"value":593209.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023."}],"balance_after":302798,"source":{"system":"sec-edgar","filing":"0001062993-23-022977","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323022977/form4.xml","form_type":"4"}},{"id":1869564,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T23:08:21.000Z","date":"2023-06-02","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":22.2511,"value":22251.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.09 to $22.39, inclusive."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001062993-23-012809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323012809/form4.xml","form_type":"4"}},{"id":1869563,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T23:08:21.000Z","date":"2023-06-02","kind":"sale","planned":true,"acquired":false,"shares":30272,"price":21.5768,"value":653172.8896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.09 to $22.085, inclusive."}],"balance_after":276000,"source":{"system":"sec-edgar","filing":"0001062993-23-012809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323012809/form4.xml","form_type":"4"}},{"id":1869562,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T23:08:21.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":31272,"price":22.0887,"value":690757.8264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.81 to $22.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":306272,"source":{"system":"sec-edgar","filing":"0001062993-23-012809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323012809/form4.xml","form_type":"4"}},{"id":1871815,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-01T20:15:53.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":31272,"price":21.8661,"value":683796.6792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.62 to $22.22, inclusive."}],"balance_after":337544,"source":{"system":"sec-edgar","filing":"0001062993-23-012623","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323012623/form4.xml","form_type":"4"}},{"id":1871814,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-01T20:15:53.000Z","date":"2023-05-30","kind":"sale","planned":true,"acquired":false,"shares":31271,"price":21.9023,"value":684906.8233,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.62 to $22.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":368816,"source":{"system":"sec-edgar","filing":"0001062993-23-012623","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323012623/form4.xml","form_type":"4"}},{"id":2016183,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-02-14T22:16:33.000Z","date":"2023-02-13","kind":"exercise","acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, initially representing a right to purchase a total of 90,00 shares, is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001062993-23-003475","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323003475/form4.xml","form_type":"4"}},{"id":2016182,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T22:16:33.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":11250,"price":26.88,"value":302400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.485 to $27.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6)."}],"balance_after":400087,"source":{"system":"sec-edgar","filing":"0001062993-23-003475","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323003475/form4.xml","form_type":"4"}},{"id":2016181,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T22:16:33.000Z","date":"2023-02-13","kind":"exercise","acquired":true,"shares":11250,"price":15.9,"value":178875.0,"ownership":{"direct":true},"balance_after":411337,"source":{"system":"sec-edgar","filing":"0001062993-23-003475","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323003475/form4.xml","form_type":"4"}},{"id":2016180,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T22:16:33.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":59736,"price":26.75,"value":1597938.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":400087,"source":{"system":"sec-edgar","filing":"0001062993-23-003475","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323003475/form4.xml","form_type":"4"}},{"id":2016179,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T22:16:33.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":44121,"price":26.75,"value":1180236.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":459823,"source":{"system":"sec-edgar","filing":"0001062993-23-003475","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323003475/form4.xml","form_type":"4"}},{"id":2016178,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T22:16:33.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":137694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 137,694 performance share units granted in the issuer's three prior fiscal years."}],"balance_after":503944,"source":{"system":"sec-edgar","filing":"0001062993-23-003475","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323003475/form4.xml","form_type":"4"}},{"id":2016177,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T22:16:33.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":117500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":366250,"source":{"system":"sec-edgar","filing":"0001062993-23-003475","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299323003475/form4.xml","form_type":"4"}},{"id":2076089,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-28T00:16:43.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":400,"price":24.19,"value":9676.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.14 to $24.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4)."}],"balance_after":248750,"source":{"system":"sec-edgar","filing":"0001062993-22-024500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322024500/form4.xml","form_type":"4"}},{"id":2076088,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-28T00:16:43.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":1804,"price":23.65,"value":42664.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3)."}],"balance_after":249150,"source":{"system":"sec-edgar","filing":"0001062993-22-024500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322024500/form4.xml","form_type":"4"}},{"id":2076087,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-28T00:16:43.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":147,"price":23,"value":3381.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2)."}],"balance_after":250954,"source":{"system":"sec-edgar","filing":"0001062993-22-024500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322024500/form4.xml","form_type":"4"}},{"id":2076086,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-28T00:16:43.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":110,"price":23,"value":2530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."}],"balance_after":251101,"source":{"system":"sec-edgar","filing":"0001062993-22-024500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322024500/form4.xml","form_type":"4"}},{"id":2078660,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-22T00:28:05.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":7333,"price":23.11,"value":169465.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4)."}],"balance_after":251211,"source":{"system":"sec-edgar","filing":"0001062993-22-024355","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322024355/form4.xml","form_type":"4"}},{"id":2078659,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-22T00:28:05.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":9375,"price":23.07,"value":216281.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3)."}],"balance_after":258544,"source":{"system":"sec-edgar","filing":"0001062993-22-024355","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322024355/form4.xml","form_type":"4"}},{"id":2078658,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-22T00:28:05.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":1134,"price":23.01,"value":26093.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2)."}],"balance_after":267919,"source":{"system":"sec-edgar","filing":"0001062993-22-024355","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322024355/form4.xml","form_type":"4"}},{"id":2095979,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-12-05T23:16:47.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":76653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the 76,653 option shares are exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":76653},"source":{"system":"sec-edgar","filing":"0001062993-22-023357","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322023357/form4.xml","form_type":"4"}},{"id":2095978,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-05T23:16:47.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":54400,"price":23.07,"value":1255008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.26, inclusive."}],"balance_after":269053,"source":{"system":"sec-edgar","filing":"0001062993-22-023357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322023357/form4.xml","form_type":"4"}},{"id":2095977,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-05T23:16:47.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":76653,"price":22.47,"value":1722392.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.95, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":323453,"source":{"system":"sec-edgar","filing":"0001062993-22-023357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322023357/form4.xml","form_type":"4"}},{"id":2095976,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-05T23:16:47.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":76653,"price":15.9,"value":1218782.7,"ownership":{"direct":true},"balance_after":400106,"source":{"system":"sec-edgar","filing":"0001062993-22-023357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322023357/form4.xml","form_type":"4"}},{"id":2101404,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-11-30T22:59:53.000Z","date":"2022-11-28","kind":"exercise","acquired":false,"shares":43,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the 43 option shares are exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":43},"source":{"system":"sec-edgar","filing":"0001062993-22-022995","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022995/form4.xml","form_type":"4"}},{"id":2101403,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-30T22:59:53.000Z","date":"2022-11-28","kind":"sale","acquired":false,"shares":43,"price":22,"value":946.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."}],"balance_after":323453,"source":{"system":"sec-edgar","filing":"0001062993-22-022995","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022995/form4.xml","form_type":"4"}},{"id":2101402,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-30T22:59:53.000Z","date":"2022-11-28","kind":"exercise","acquired":true,"shares":43,"price":15.9,"value":683.7,"ownership":{"direct":true},"balance_after":323496,"source":{"system":"sec-edgar","filing":"0001062993-22-022995","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022995/form4.xml","form_type":"4"}},{"id":2104159,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-11-25T23:11:50.000Z","date":"2022-11-22","kind":"exercise","acquired":false,"shares":65,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the 65 option shares are exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":65},"source":{"system":"sec-edgar","filing":"0001062993-22-022779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022779/form4.xml","form_type":"4"}},{"id":2104158,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-25T23:11:50.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":65,"price":22,"value":1430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."}],"balance_after":323453,"source":{"system":"sec-edgar","filing":"0001062993-22-022779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022779/form4.xml","form_type":"4"}},{"id":2104157,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-25T23:11:50.000Z","date":"2022-11-22","kind":"exercise","acquired":true,"shares":65,"price":15.9,"value":1033.5,"ownership":{"direct":true},"balance_after":323518,"source":{"system":"sec-edgar","filing":"0001062993-22-022779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022779/form4.xml","form_type":"4"}},{"id":2106818,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-11-22T21:44:40.000Z","date":"2022-11-18","kind":"exercise","acquired":false,"shares":1989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the 1,989 option shares are exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":1989},"source":{"system":"sec-edgar","filing":"0001062993-22-022644","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022644/form4.xml","form_type":"4"}},{"id":2106817,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-22T21:44:40.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":1989,"price":22.02,"value":43797.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":323453,"source":{"system":"sec-edgar","filing":"0001062993-22-022644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022644/form4.xml","form_type":"4"}},{"id":2106816,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-22T21:44:40.000Z","date":"2022-11-18","kind":"exercise","acquired":true,"shares":1989,"price":15.9,"value":31625.1,"ownership":{"direct":true},"balance_after":325442,"source":{"system":"sec-edgar","filing":"0001062993-22-022644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322022644/form4.xml","form_type":"4"}},{"id":2211796,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-06T20:35:38.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":1394,"price":18.16,"value":25315.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":323453,"source":{"system":"sec-edgar","filing":"0001062993-22-016068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322016068/form4.xml","form_type":"4"}},{"id":2353949,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T21:14:29.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":11011,"price":19.04,"value":209649.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.91 to $19.35, inclusive."}],"balance_after":324847,"source":{"system":"sec-edgar","filing":"0001062993-22-006644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322006644/form4.xml","form_type":"4"}},{"id":2353948,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T21:14:29.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":65083,"price":18.37,"value":1195574.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.90 to $18.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":335858,"source":{"system":"sec-edgar","filing":"0001062993-22-006644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322006644/form4.xml","form_type":"4"}},{"id":2397760,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T23:37:48.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":28843,"price":17.63,"value":508502.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":400941,"source":{"system":"sec-edgar","filing":"0001062993-22-004320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322004320/form4.xml","form_type":"4"}},{"id":2397759,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T23:37:48.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":24154,"price":17.63,"value":425835.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":429784,"source":{"system":"sec-edgar","filing":"0001062993-22-004320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322004320/form4.xml","form_type":"4"}},{"id":2397758,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T23:37:48.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":65034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 65,034 performance share units granted in the issuer's three prior fiscal years."}],"balance_after":453938,"source":{"system":"sec-edgar","filing":"0001062993-22-004320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322004320/form4.xml","form_type":"4"}},{"id":2397757,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T23:37:48.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":388904,"source":{"system":"sec-edgar","filing":"0001062993-22-004320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000106299322004320/form4.xml","form_type":"4"}},{"id":2443725,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-05T21:06:02.000Z","date":"2022-01-03","kind":"tax_withholding","acquired":false,"shares":1090,"price":18.68,"value":20361.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":263904,"source":{"system":"sec-edgar","filing":"0001879789-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000187978922000001/primary_doc.xml","form_type":"4"}},{"id":2605309,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-12T20:01:48.000Z","date":"2021-08-10","kind":"tax_withholding","acquired":false,"shares":1386,"price":19.03,"value":26375.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":264994,"source":{"system":"sec-edgar","filing":"0001192482-21-000661","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000661/edgar.xml","form_type":"4"}},{"id":2641067,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T20:03:08.000Z","date":"2021-07-01","kind":"tax_withholding","acquired":false,"shares":1394,"price":23.99,"value":33442.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":266380,"source":{"system":"sec-edgar","filing":"0001192482-21-000623","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000623/edgar.xml","form_type":"4"}},{"id":2683098,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-06-03T20:16:28.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":16205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All of the 16,205 option shares are exercisable."}],"balance_after":0,"derivative":{"exercise_price":8.22,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":16205},"source":{"system":"sec-edgar","filing":"0001192482-21-000479","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000479/edgar.xml","form_type":"4"}},{"id":2683097,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-03T20:16:28.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":5861,"price":22.81,"value":133689.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020."}],"balance_after":267774,"source":{"system":"sec-edgar","filing":"0001192482-21-000479","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000479/edgar.xml","form_type":"4"}},{"id":2683096,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-03T20:16:28.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":10829,"price":23.33,"value":252640.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.88, inclusive."}],"balance_after":273635,"source":{"system":"sec-edgar","filing":"0001192482-21-000479","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000479/edgar.xml","form_type":"4"}},{"id":2683095,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-03T20:16:28.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":5376,"price":22.93,"value":123271.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.79 to $22.99, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4)."}],"balance_after":284464,"source":{"system":"sec-edgar","filing":"0001192482-21-000479","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000479/edgar.xml","form_type":"4"}},{"id":2683094,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-03T20:16:28.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":16205,"price":8.22,"value":133205.1,"ownership":{"direct":true},"balance_after":289840,"source":{"system":"sec-edgar","filing":"0001192482-21-000479","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000479/edgar.xml","form_type":"4"}},{"id":2683093,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-03T20:16:28.000Z","date":"2021-06-01","kind":"tax_withholding","acquired":false,"shares":4672,"price":22.9,"value":106988.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":273635,"source":{"system":"sec-edgar","filing":"0001192482-21-000479","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000479/edgar.xml","form_type":"4"}},{"id":2812831,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-03-04T01:02:39.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":48616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"48,616 shares under the option are exercisable. The option, initially representing a right to purchase a total of 259,283 shares, vests and becomes exercisable over a four-year period commencing on May 31, 2017. Twenty-five percent (25%) of the option vested and became exercisable on May 31, 2018 and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) at the end of each quarterly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the Issuer."}],"balance_after":16205,"derivative":{"exercise_price":8.22,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":48616},"source":{"system":"sec-edgar","filing":"0001192482-21-000212","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000212/edgar.xml","form_type":"4"}},{"id":2812830,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-04T01:02:39.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":9809,"price":23.3,"value":228549.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.54, inclusive."}],"balance_after":278307,"source":{"system":"sec-edgar","filing":"0001192482-21-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000212/edgar.xml","form_type":"4"}},{"id":2812829,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-04T01:02:39.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":54959,"price":22.56,"value":1239875.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.01 to $22.98, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3)."}],"balance_after":288116,"source":{"system":"sec-edgar","filing":"0001192482-21-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000212/edgar.xml","form_type":"4"}},{"id":2812828,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-04T01:02:39.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":48616,"price":8.22,"value":399623.52,"ownership":{"direct":true},"balance_after":343075,"source":{"system":"sec-edgar","filing":"0001192482-21-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000212/edgar.xml","form_type":"4"}},{"id":2863130,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T21:15:07.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":15288,"price":25.95,"value":396723.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":294459,"source":{"system":"sec-edgar","filing":"0001192482-21-000148","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000148/edgar.xml","form_type":"4"}},{"id":2863129,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T21:15:07.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":8498,"price":25.95,"value":220523.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":309747,"source":{"system":"sec-edgar","filing":"0001192482-21-000148","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000148/edgar.xml","form_type":"4"}},{"id":2899140,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-22T21:13:51.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":28989,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 28,989 performance share units granted in two prior years."}],"balance_after":318245,"source":{"system":"sec-edgar","filing":"0001192482-21-000103","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000103/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2899139,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-22T21:13:51.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":289256,"source":{"system":"sec-edgar","filing":"0001192482-21-000103","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000103/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2900612,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-01-21T21:28:18.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2022, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":420000,"derivative":{"exercise_price":24.06,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001192482-21-000083","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000083/edgar.xml","form_type":"4"}},{"id":2900611,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-21T21:28:18.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":28989,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 28,989 performance share units granted in two prior years."}],"balance_after":318245,"source":{"system":"sec-edgar","filing":"0001192482-21-000083","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000083/edgar.xml","form_type":"4"}},{"id":2900610,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-21T21:28:18.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":289256,"source":{"system":"sec-edgar","filing":"0001192482-21-000083","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000083/edgar.xml","form_type":"4"}},{"id":2915378,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-06T21:09:17.000Z","date":"2021-01-04","kind":"tax_withholding","acquired":false,"shares":1090,"price":20.03,"value":21832.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":184256,"source":{"system":"sec-edgar","filing":"0001192482-21-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248221000045/edgar.xml","form_type":"4"}},{"id":2960700,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-02T22:00:19.000Z","date":"2020-11-30","kind":"tax_withholding","acquired":false,"shares":4672,"price":18.49,"value":86385.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":185346,"source":{"system":"sec-edgar","filing":"0001192482-20-000797","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000797/edgar.xml","form_type":"4"}},{"id":3060148,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-12T20:05:45.000Z","date":"2020-08-10","kind":"tax_withholding","acquired":false,"shares":1386,"price":18.89,"value":26181.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":190018,"source":{"system":"sec-edgar","filing":"0001192482-20-000667","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000667/edgar.xml","form_type":"4"}},{"id":3091640,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-02T20:40:45.000Z","date":"2020-07-01","kind":"tax_withholding","acquired":false,"shares":1394,"price":17.37,"value":24213.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":191404,"source":{"system":"sec-edgar","filing":"0001192482-20-000600","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000600/edgar.xml","form_type":"4"}},{"id":3126907,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-06-02T22:58:31.000Z","date":"2020-06-01","kind":"exercise","acquired":false,"shares":64820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"64,820 shares under the option are exercisable. The option, initially representing a right to purchase a total of 259,283 shares, vests and becomes exercisable over a four-year period commencing on May 31, 2017. Twenty-five percent (25%) of the option vested and became exercisable on May 31, 2018 and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) at the end of each quarterly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the Issuer."}],"balance_after":64821,"derivative":{"exercise_price":8.22,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":64820},"source":{"system":"sec-edgar","filing":"0001192482-20-000418","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000418/edgar.xml","form_type":"4"}},{"id":3126906,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T22:58:31.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":100,"price":21.3,"value":2130.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019."}],"balance_after":192798,"source":{"system":"sec-edgar","filing":"0001192482-20-000418","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000418/edgar.xml","form_type":"4"}},{"id":3126905,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T22:58:31.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":5761,"price":20.47,"value":117927.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.18 to $20.92, inclusive."}],"balance_after":192898,"source":{"system":"sec-edgar","filing":"0001192482-20-000418","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000418/edgar.xml","form_type":"4"}},{"id":3126904,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T22:58:31.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":100,"price":22.08,"value":2208.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019."}],"balance_after":198659,"source":{"system":"sec-edgar","filing":"0001192482-20-000418","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000418/edgar.xml","form_type":"4"}},{"id":3126903,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T22:58:31.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":70576,"price":21.53,"value":1519501.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.05 to $22.02, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4)."}],"balance_after":198759,"source":{"system":"sec-edgar","filing":"0001192482-20-000418","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000418/edgar.xml","form_type":"4"}},{"id":3126902,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T22:58:31.000Z","date":"2020-06-01","kind":"exercise","acquired":true,"shares":64820,"price":8.22,"value":532820.4,"ownership":{"direct":true},"balance_after":269335,"source":{"system":"sec-edgar","filing":"0001192482-20-000418","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000418/edgar.xml","form_type":"4"}},{"id":3126901,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T22:58:31.000Z","date":"2020-06-01","kind":"tax_withholding","acquired":false,"shares":4672,"price":21.24,"value":99233.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":204515,"source":{"system":"sec-edgar","filing":"0001192482-20-000418","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000418/edgar.xml","form_type":"4"}},{"id":3276913,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-12T21:30:32.000Z","date":"2020-02-10","kind":"tax_withholding","acquired":false,"shares":7499,"price":21.62,"value":162128.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":209187,"source":{"system":"sec-edgar","filing":"0001192482-20-000152","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000152/edgar.xml","form_type":"4"}},{"id":3284407,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-07T21:08:57.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":90000,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001192482-20-000135","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000135/edgar.xml","form_type":"4"}},{"id":3284406,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-07T21:08:57.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":216686,"source":{"system":"sec-edgar","filing":"0001192482-20-000135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000135/edgar.xml","form_type":"4"}},{"id":3322780,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-03T21:07:01.000Z","date":"2020-01-02","kind":"tax_withholding","acquired":false,"shares":1091,"price":20.58,"value":22452.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":171686,"source":{"system":"sec-edgar","filing":"0001192482-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248220000002/edgar.xml","form_type":"4"}},{"id":3355808,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-02T21:16:39.000Z","date":"2019-11-29","kind":"tax_withholding","acquired":false,"shares":4678,"price":21.73,"value":101652.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":172777,"source":{"system":"sec-edgar","filing":"0001192482-19-000451","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248219000451/edgar.xml","form_type":"4"}},{"id":3376366,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-11-08T21:11:58.000Z","date":"2019-11-07","kind":"exercise","acquired":false,"shares":64821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"81,026 shares under the option are exercisable. The option, initially representing a right to purchase a total of 259,283 shares, vests and becomes exercisable over a four-year period commencing on May 31, 2017. Twenty-five percent (25%) of the option vested and became exercisable on May 31, 2018 and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) at the end of each quarterly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the Issuer."}],"balance_after":129641,"derivative":{"exercise_price":8.22,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":64821},"source":{"system":"sec-edgar","filing":"0001192482-19-000392","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248219000392/edgar.xml","form_type":"4"}},{"id":3376365,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-08T21:11:58.000Z","date":"2019-11-07","kind":"sale","acquired":false,"shares":31226,"price":19.16,"value":598290.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018."}],"balance_after":177455,"source":{"system":"sec-edgar","filing":"0001192482-19-000392","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248219000392/edgar.xml","form_type":"4"}},{"id":3376364,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-08T21:11:58.000Z","date":"2019-11-07","kind":"sale","acquired":false,"shares":33595,"price":18.41,"value":618483.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.13 to $18.53, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":208681,"source":{"system":"sec-edgar","filing":"0001192482-19-000392","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248219000392/edgar.xml","form_type":"4"}},{"id":3376363,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-08T21:11:58.000Z","date":"2019-11-07","kind":"exercise","acquired":true,"shares":64821,"price":8.22,"value":532828.62,"ownership":{"direct":true},"balance_after":242276,"source":{"system":"sec-edgar","filing":"0001192482-19-000392","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248219000392/edgar.xml","form_type":"4"}},{"id":3439924,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-13T20:46:42.000Z","date":"2019-08-09","kind":"tax_withholding","acquired":false,"shares":919,"price":11.24,"value":10329.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":177455,"source":{"system":"sec-edgar","filing":"0001192482-19-000339","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443841/000119248219000339/edgar.xml","form_type":"4"}}],"next_cursor":"2019-08-13T20:46:42.000000Z,3439924"}